Sparrow Pharmaceuticals
Clinical trials sponsored by Sparrow Pharmaceuticals, explained in plain language.
-
New pill targets hormone imbalance from adrenal growths
Disease control CompletedThis study tested a daily pill called SPI-62 in 30 adults with high cortisol levels caused by a non-cancerous adrenal tumor. The goal was to see if the drug could improve blood sugar control and reduce cortisol-related health problems. Participants took 2 mg of SPI-62 each day fo…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:39 UTC
-
New pill shows promise for controlling Cushing's syndrome in early trial
Disease control CompletedThis study tested an experimental drug called SPI-62 in 26 adults with Cushing's syndrome caused by too much ACTH hormone. Participants received either SPI-62 or a placebo for 24 weeks, with an option to continue longer. The main goal was to see if the drug lowers a liver biomark…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New drug interaction study completed in healthy volunteers
Knowledge-focused CompletedThis study looked at whether a new drug called clofutriben affects how the body processes two other drugs, midazolam and prednisolone. Sixteen healthy adults took clofutriben daily for 16 days along with single doses of the other drugs. The goal was to measure drug levels in the …
Phase: PHASE1 • Sponsor: Sparrow Pharmaceuticals • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC